IBDEI0S8 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,37292,1,4,0)
 ;;=4^I69.021
 ;;^UTILITY(U,$J,358.3,37292,2)
 ;;=^5007396
 ;;^UTILITY(U,$J,358.3,37293,0)
 ;;=I69.821^^106^1587^31
 ;;^UTILITY(U,$J,358.3,37293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37293,1,3,0)
 ;;=3^Dysphasia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,37293,1,4,0)
 ;;=4^I69.821
 ;;^UTILITY(U,$J,358.3,37293,2)
 ;;=^5007523
 ;;^UTILITY(U,$J,358.3,37294,0)
 ;;=I69.221^^106^1587^30
 ;;^UTILITY(U,$J,358.3,37294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37294,1,3,0)
 ;;=3^Dysphasia following oth nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,37294,1,4,0)
 ;;=4^I69.221
 ;;^UTILITY(U,$J,358.3,37294,2)
 ;;=^5007460
 ;;^UTILITY(U,$J,358.3,37295,0)
 ;;=G11.1^^106^1587^32
 ;;^UTILITY(U,$J,358.3,37295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37295,1,3,0)
 ;;=3^Early-onset cerebellar ataxia
 ;;^UTILITY(U,$J,358.3,37295,1,4,0)
 ;;=4^G11.1
 ;;^UTILITY(U,$J,358.3,37295,2)
 ;;=^5003753
 ;;^UTILITY(U,$J,358.3,37296,0)
 ;;=I69.392^^106^1587^33
 ;;^UTILITY(U,$J,358.3,37296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37296,1,3,0)
 ;;=3^Facial weakness following cerebral infarction
 ;;^UTILITY(U,$J,358.3,37296,1,4,0)
 ;;=4^I69.392
 ;;^UTILITY(U,$J,358.3,37296,2)
 ;;=^5007517
 ;;^UTILITY(U,$J,358.3,37297,0)
 ;;=I69.192^^106^1587^34
 ;;^UTILITY(U,$J,358.3,37297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37297,1,3,0)
 ;;=3^Facial weakness following nontraumatic intcrbl hemorrhage
 ;;^UTILITY(U,$J,358.3,37297,1,4,0)
 ;;=4^I69.192
 ;;^UTILITY(U,$J,358.3,37297,2)
 ;;=^5007454
 ;;^UTILITY(U,$J,358.3,37298,0)
 ;;=I69.292^^106^1587^36
 ;;^UTILITY(U,$J,358.3,37298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37298,1,3,0)
 ;;=3^Facial weakness following oth nontraumatic intcrn hemorrhage
 ;;^UTILITY(U,$J,358.3,37298,1,4,0)
 ;;=4^I69.292
 ;;^UTILITY(U,$J,358.3,37298,2)
 ;;=^5007486
 ;;^UTILITY(U,$J,358.3,37299,0)
 ;;=I69.092^^106^1587^35
 ;;^UTILITY(U,$J,358.3,37299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37299,1,3,0)
 ;;=3^Facial weakness following ntrm subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,37299,1,4,0)
 ;;=4^I69.092
 ;;^UTILITY(U,$J,358.3,37299,2)
 ;;=^5007422
 ;;^UTILITY(U,$J,358.3,37300,0)
 ;;=I69.892^^106^1587^37
 ;;^UTILITY(U,$J,358.3,37300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37300,1,3,0)
 ;;=3^Facial weakness following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,37300,1,4,0)
 ;;=4^I69.892
 ;;^UTILITY(U,$J,358.3,37300,2)
 ;;=^5007548
 ;;^UTILITY(U,$J,358.3,37301,0)
 ;;=I69.351^^106^1587^39
 ;;^UTILITY(U,$J,358.3,37301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37301,1,3,0)
 ;;=3^Hemiplga fol cerebral infrc aff right dominant side
 ;;^UTILITY(U,$J,358.3,37301,1,4,0)
 ;;=4^I69.351
 ;;^UTILITY(U,$J,358.3,37301,2)
 ;;=^5007504
 ;;^UTILITY(U,$J,358.3,37302,0)
 ;;=I69.352^^106^1587^38
 ;;^UTILITY(U,$J,358.3,37302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37302,1,3,0)
 ;;=3^Hemiplga fol cerebral infrc aff left dominant side
 ;;^UTILITY(U,$J,358.3,37302,1,4,0)
 ;;=4^I69.352
 ;;^UTILITY(U,$J,358.3,37302,2)
 ;;=^5007505
 ;;^UTILITY(U,$J,358.3,37303,0)
 ;;=I69.353^^106^1587^40
 ;;^UTILITY(U,$J,358.3,37303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37303,1,3,0)
 ;;=3^Hemiplga fol cerebral infrc aff right nondom side
 ;;^UTILITY(U,$J,358.3,37303,1,4,0)
 ;;=4^I69.353
 ;;^UTILITY(U,$J,358.3,37303,2)
 ;;=^5007506
 ;;^UTILITY(U,$J,358.3,37304,0)
 ;;=I69.354^^106^1587^41
 ;;^UTILITY(U,$J,358.3,37304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37304,1,3,0)
 ;;=3^Hemiplga fol cerebral infrc affecting left nondom side
 ;;^UTILITY(U,$J,358.3,37304,1,4,0)
 ;;=4^I69.354
 ;;^UTILITY(U,$J,358.3,37304,2)
 ;;=^5007507
 ;;^UTILITY(U,$J,358.3,37305,0)
 ;;=I69.151^^106^1587^44
 ;;^UTILITY(U,$J,358.3,37305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37305,1,3,0)
 ;;=3^Hemiplga fol ntrm intcrbl hemor aff right dominant side
 ;;^UTILITY(U,$J,358.3,37305,1,4,0)
 ;;=4^I69.151
 ;;^UTILITY(U,$J,358.3,37305,2)
 ;;=^5007441
 ;;^UTILITY(U,$J,358.3,37306,0)
 ;;=I69.152^^106^1587^42
 ;;^UTILITY(U,$J,358.3,37306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37306,1,3,0)
 ;;=3^Hemiplga fol ntrm intcrbl hemor aff left dominant side
 ;;^UTILITY(U,$J,358.3,37306,1,4,0)
 ;;=4^I69.152
 ;;^UTILITY(U,$J,358.3,37306,2)
 ;;=^5007442
 ;;^UTILITY(U,$J,358.3,37307,0)
 ;;=I69.153^^106^1587^45
 ;;^UTILITY(U,$J,358.3,37307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37307,1,3,0)
 ;;=3^Hemiplga fol ntrm intcrbl hemor aff right nondom side
 ;;^UTILITY(U,$J,358.3,37307,1,4,0)
 ;;=4^I69.153
 ;;^UTILITY(U,$J,358.3,37307,2)
 ;;=^5007443
 ;;^UTILITY(U,$J,358.3,37308,0)
 ;;=I69.154^^106^1587^43
 ;;^UTILITY(U,$J,358.3,37308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37308,1,3,0)
 ;;=3^Hemiplga fol ntrm intcrbl hemor aff left nondom side
 ;;^UTILITY(U,$J,358.3,37308,1,4,0)
 ;;=4^I69.154
 ;;^UTILITY(U,$J,358.3,37308,2)
 ;;=^5007444
 ;;^UTILITY(U,$J,358.3,37309,0)
 ;;=I69.851^^106^1587^50
 ;;^UTILITY(U,$J,358.3,37309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37309,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff right dominant side
 ;;^UTILITY(U,$J,358.3,37309,1,4,0)
 ;;=4^I69.851
 ;;^UTILITY(U,$J,358.3,37309,2)
 ;;=^5007535
 ;;^UTILITY(U,$J,358.3,37310,0)
 ;;=I69.852^^106^1587^51
 ;;^UTILITY(U,$J,358.3,37310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37310,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff left dominant side
 ;;^UTILITY(U,$J,358.3,37310,1,4,0)
 ;;=4^I69.852
 ;;^UTILITY(U,$J,358.3,37310,2)
 ;;=^5007536
 ;;^UTILITY(U,$J,358.3,37311,0)
 ;;=I69.853^^106^1587^52
 ;;^UTILITY(U,$J,358.3,37311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37311,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff right nondom side
 ;;^UTILITY(U,$J,358.3,37311,1,4,0)
 ;;=4^I69.853
 ;;^UTILITY(U,$J,358.3,37311,2)
 ;;=^5007537
 ;;^UTILITY(U,$J,358.3,37312,0)
 ;;=I69.854^^106^1587^53
 ;;^UTILITY(U,$J,358.3,37312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37312,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff left nondom side
 ;;^UTILITY(U,$J,358.3,37312,1,4,0)
 ;;=4^I69.854
 ;;^UTILITY(U,$J,358.3,37312,2)
 ;;=^5007538
 ;;^UTILITY(U,$J,358.3,37313,0)
 ;;=I69.251^^106^1587^54
 ;;^UTILITY(U,$J,358.3,37313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37313,1,3,0)
 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff right dominant side
 ;;^UTILITY(U,$J,358.3,37313,1,4,0)
 ;;=4^I69.251
 ;;^UTILITY(U,$J,358.3,37313,2)
 ;;=^5007473
 ;;^UTILITY(U,$J,358.3,37314,0)
 ;;=I69.252^^106^1587^55
 ;;^UTILITY(U,$J,358.3,37314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37314,1,3,0)
 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff left dominant side
 ;;^UTILITY(U,$J,358.3,37314,1,4,0)
 ;;=4^I69.252
 ;;^UTILITY(U,$J,358.3,37314,2)
 ;;=^5007474
 ;;^UTILITY(U,$J,358.3,37315,0)
 ;;=I69.253^^106^1587^56
 ;;^UTILITY(U,$J,358.3,37315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37315,1,3,0)
 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff right nondom side
 ;;^UTILITY(U,$J,358.3,37315,1,4,0)
 ;;=4^I69.253
 ;;^UTILITY(U,$J,358.3,37315,2)
 ;;=^5007475
 ;;^UTILITY(U,$J,358.3,37316,0)
 ;;=I69.254^^106^1587^57
 ;;^UTILITY(U,$J,358.3,37316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37316,1,3,0)
 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff left nondom side
 ;;^UTILITY(U,$J,358.3,37316,1,4,0)
 ;;=4^I69.254
 ;;^UTILITY(U,$J,358.3,37316,2)
 ;;=^5007476
 ;;^UTILITY(U,$J,358.3,37317,0)
 ;;=I69.341^^106^1587^58
 ;;^UTILITY(U,$J,358.3,37317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37317,1,3,0)
 ;;=3^Monoplg low lmb fol cerebral infrc aff right dominant side
 ;;^UTILITY(U,$J,358.3,37317,1,4,0)
 ;;=4^I69.341
 ;;^UTILITY(U,$J,358.3,37317,2)
 ;;=^5007501
 ;;^UTILITY(U,$J,358.3,37318,0)
 ;;=I69.342^^106^1587^59
 ;;^UTILITY(U,$J,358.3,37318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37318,1,3,0)
 ;;=3^Monoplg low lmb fol cerebral infrc aff left dominant side
 ;;^UTILITY(U,$J,358.3,37318,1,4,0)
 ;;=4^I69.342
 ;;^UTILITY(U,$J,358.3,37318,2)
 ;;=^5133575
 ;;^UTILITY(U,$J,358.3,37319,0)
 ;;=I69.343^^106^1587^60
 ;;^UTILITY(U,$J,358.3,37319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37319,1,3,0)
 ;;=3^Monoplg low lmb fol cerebral infrc aff right nondom side
 ;;^UTILITY(U,$J,358.3,37319,1,4,0)
 ;;=4^I69.343
 ;;^UTILITY(U,$J,358.3,37319,2)
 ;;=^5007502
 ;;^UTILITY(U,$J,358.3,37320,0)
 ;;=I69.344^^106^1587^61
 ;;^UTILITY(U,$J,358.3,37320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37320,1,3,0)
 ;;=3^Monoplg low lmb fol cerebral infrc aff left nondom side
 ;;^UTILITY(U,$J,358.3,37320,1,4,0)
 ;;=4^I69.344
 ;;^UTILITY(U,$J,358.3,37320,2)
 ;;=^5133576
 ;;^UTILITY(U,$J,358.3,37321,0)
 ;;=I69.141^^106^1587^62
 ;;^UTILITY(U,$J,358.3,37321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37321,1,3,0)
 ;;=3^Monoplg low lmb fol ntrm intcrbl hemor aff right dom side
 ;;^UTILITY(U,$J,358.3,37321,1,4,0)
 ;;=4^I69.141
 ;;^UTILITY(U,$J,358.3,37321,2)
 ;;=^5007437
 ;;^UTILITY(U,$J,358.3,37322,0)
 ;;=I69.142^^106^1587^63
 ;;^UTILITY(U,$J,358.3,37322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37322,1,3,0)
 ;;=3^Monoplg low lmb fol ntrm intcrbl hemor aff left dom side
 ;;^UTILITY(U,$J,358.3,37322,1,4,0)
 ;;=4^I69.142
 ;;^UTILITY(U,$J,358.3,37322,2)
 ;;=^5133573
 ;;^UTILITY(U,$J,358.3,37323,0)
 ;;=I69.143^^106^1587^64
 ;;^UTILITY(U,$J,358.3,37323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37323,1,3,0)
 ;;=3^Monoplg low lmb fol ntrm intcrbl hemor aff right nondom side
 ;;^UTILITY(U,$J,358.3,37323,1,4,0)
 ;;=4^I69.143
 ;;^UTILITY(U,$J,358.3,37323,2)
 ;;=^5007438
 ;;^UTILITY(U,$J,358.3,37324,0)
 ;;=I69.144^^106^1587^65
 ;;^UTILITY(U,$J,358.3,37324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37324,1,3,0)
 ;;=3^Monoplg low lmb fol ntrm intcrbl hemor aff left nondom side
 ;;^UTILITY(U,$J,358.3,37324,1,4,0)
 ;;=4^I69.144
 ;;^UTILITY(U,$J,358.3,37324,2)
 ;;=^5007439
 ;;^UTILITY(U,$J,358.3,37325,0)
 ;;=I69.041^^106^1587^66
